Skip to content
Longterm Wiki
Back

collaboration between SecureBio and MIT

web
naobservatory.org·naobservatory.org/

Relevant to AI safety audiences concerned with biological x-risks and dual-use threats; NAO's metagenomic surveillance infrastructure could also apply to detecting engineered or AI-assisted pathogen releases.

Metadata

Importance: 52/100homepage

Summary

The Nucleic Acid Observatory (NAO), a collaboration between SecureBio and MIT's Sculpting Evolution group, develops pathogen-agnostic biosurveillance systems capable of detecting novel pandemic threats before widespread transmission. Their approach combines computational threat detection, large-scale monitoring evaluation (including wastewater surveillance), and real-world pilot deployments to build early warning infrastructure against biological catastrophes, including engineered pathogens.

Key Points

  • Founded in 2021 at MIT, now operating under SecureBio; focuses on detecting novel pandemic pathogens without known precursors.
  • Prioritizes pathogen-agnostic surveillance using municipal and airplane wastewater as primary monitoring sources.
  • Develops computational tools for identifying threatening organisms in sequencing data, emphasizing temporal growth pattern analysis.
  • Actively deploying a functional early warning demonstration system, iterating from specific threat categories toward broader capabilities.
  • Addresses a key biosecurity gap: detecting threats potentially resistant to conventional or anticipated surveillance frameworks.

Cited by 1 page

PageTypeQuality
Bioweapons RiskRisk91.0

Cached Content Preview

HTTP 200Fetched Mar 20, 20263 KB
**The world is demonstrably vulnerable to biological threats.** COVID-19 represented significant disruption, but emerging pandemics could prove substantially more severe. Protecting civilization requires systems capable of detecting novel pandemic pathogens before widespread transmission—including those without known precursors.

SecureBio Detection was founded in 2021 as the Nucleic Acid Observatory project in MIT’s Sculpting Evolution group, before spinning out under SecureBio. Our mission involves creating new disease surveillance methods for identifying pandemic threats, particularly pathogens potentially resistant to conventional or anticipated surveillance frameworks.

Our strategy combines:

- **Models and experiments** assessing large-scale monitoring effectiveness
- **Novel computational approaches** enabling reliable, early threat identification
- **Operational systems** validating methods through real-world pilot deployment

Explore our [research](https://securebio.org/resources/), review [career opportunities](https://securebio.org/careers/), or consider [financial support](https://securebio.org/donate/).

## Research Areas [Anchor](https://securebio.org/detection/\#research-areas)

### Evaluating biosurveillance approaches [Anchor](https://securebio.org/detection/\#evaluating-biosurveillance-approaches)

_Understanding & comparing large-scale monitoring approaches_

Disease surveillance employs diverse detection methodologies. For us, identifying sensitive, dependable, and economical pathogen-agnostic approaches represents the central challenge. Through modeling, analysis, and empirical investigation, we evaluate comparative effectiveness—prioritizing municipal and airplane wastewater sources.

### Computational threat detection [Anchor](https://securebio.org/detection/\#computational-threat-detection)

_Designing new methods to detect pathogens in sequencing data_

Identifying emerging pathogens requires distinguishing target sequences from complex microbial backgrounds. Our researchers develop and refine computational tools for recognizing threatening organisms in sequence datasets, emphasizing temporal growth pattern analysis.

### Piloting early warning [Anchor](https://securebio.org/detection/\#piloting-early-warning)

_Putting our research into practice_

We are deploying a functional early warning demonstration, initially targeting specific threat categories before expanding capabilities. Through iterative refinement and operational learning, we integrate research insights into comprehensive threat detection.

SecureBio Detection, founded 2021, operates under SecureBio. Contact: detection-inquiries@securebio.org
Resource ID: 66f6f860844300d7 | Stable ID: MmJkNDUwNm